ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Insmed Receives FDA Breakthrough Therapy Designation for Non-Cystic Fibrosis Bronchiectasis Treatment
June 17, 2020Insmed announced the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for brensocatib (formerly known as INS1007) for the treatment of adult patients with non-cystic fibrosis bronchiectasis (NCFBE) for reducing ...
Pharma Sources Insight January 2025
